134 related articles for article (PubMed ID: 6661733)
1. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study.
Mouridsen HT; Rose C; Nooy MA; van Oosterom AT
Cancer Treat Rev; 1983 Dec; 10 Suppl B():47-52. PubMed ID: 6661734
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone: an active new agent in the treatment of advanced breast cancer.
Stuart-Harris RC; Bozek T; Pavlidis NA; Smith IE
Cancer Chemother Pharmacol; 1984; 12(1):1-4. PubMed ID: 6690066
[TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone: a phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours.
Stuart-Harris RC; Smith IE
Cancer Chemother Pharmacol; 1982; 8(2):179-82. PubMed ID: 7105382
[TBL] [Abstract][Full Text] [Related]
5. First-line mitoxantrone chemotherapy for advanced breast cancer.
Wilson KS; Paterson AH
Cancer Treat Rep; 1986 Aug; 70(8):1021-2. PubMed ID: 3731148
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone and cyclophosphamide in patients with advanced breast cancer.
Ehninger G; Weible KH; Heidemann EG; Waller HD
Cancer Treat Rep; 1984 Oct; 68(10):1283-4. PubMed ID: 6525600
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.
Mouridsen HT; Cornbleet M; Stuart-Harris R; Smith I; Coleman R; Rubens R; McDonald M; Rainer H; van Oosterom A; Smyth J
Invest New Drugs; 1985; 3(2):139-48. PubMed ID: 4019118
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients.
Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT; Smyth JF
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1141-6. PubMed ID: 6541135
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicity.
Perren TJ; Blackledge G; Mould JJ; Chetiyawardana AD; Morrison M; Hancock A
Invest New Drugs; 1985; 3(2):173-7. PubMed ID: 3926713
[TBL] [Abstract][Full Text] [Related]
10. [Phase II study of mitoxantrone in advanced breast cancer].
Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
[TBL] [Abstract][Full Text] [Related]
11. First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer.
Periti P; della Cuna GR; Pannuti F; Mazzei T; Preti P; Martoni A; Mini E
Invest New Drugs; 1985; 3(2):167-71. PubMed ID: 4019120
[TBL] [Abstract][Full Text] [Related]
12. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone, methotrexate, and 5-fluorouracil combination chemotherapy as first-line treatment in stage IV breast cancer.
Bezwoda WR; Hesdorffer CS
Cancer; 1986 Jan; 57(2):218-21. PubMed ID: 3753656
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with cyclophosphamide, mitoxantrone and 5-fluorouracil in patients with metastatic breast cancer.
Yap HY; Esparza L; Blumenschein GR; Hortobagyi GN; Bodey GP
Cancer Treat Rev; 1983 Dec; 10 Suppl B():53-5. PubMed ID: 6661735
[No Abstract] [Full Text] [Related]
15. Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicity.
Coleman RE; Maisey MN; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):771-6. PubMed ID: 6540179
[TBL] [Abstract][Full Text] [Related]
16. Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancer.
Talbot DC; Smith IE; Mansi JL; Judson I; Calvert AH; Ashley SE
J Clin Oncol; 1991 Dec; 9(12):2141-7. PubMed ID: 1960556
[TBL] [Abstract][Full Text] [Related]
17. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
Ito Y; Hoshino A; Ohara K; Kamiya O; Nagata K; Kojima T; Kinoshita T; Sugiura I
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
[TBL] [Abstract][Full Text] [Related]
18. Combined cytotoxic and endocrine treatment of postmenopausal patients with advanced breast cancer: preliminary results of a phase II study of the combination of prednimustine, novantrone, methotrexate, 5-fluorouracil, and tamoxifen.
Mouridsen HT; Andersson M; Pedersen L
Semin Oncol; 1986 Mar; 13(1 Suppl 1):39-41. PubMed ID: 3952520
[TBL] [Abstract][Full Text] [Related]
19. First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
Bafaloukos D; Samonis G; Klinaki A; Daliani D; Karvounis N; Bacoyiannis C; Karabelis A; Milonakis N; Kosmidis P
Eur J Cancer; 1993; 29A(6):851-3. PubMed ID: 8484975
[TBL] [Abstract][Full Text] [Related]
20. First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
Samonis G; Bafaloukos D; Margioris AN; Katsarma G; Toloudis P; Bacoyannis C; Karvounis N; Georgoulias V; Kosmidis P
Oncology; 1997; 54(5):371-5. PubMed ID: 9260597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
